iZola, a leading health-tech startup specialising in solutions for parents of children with neuro-divergent conditions such as Autism Spectrum Disorder (ASD), has appointed Dr Leah Kirumbi as Chief Medical Advisor.
Dr Leah Kirumbi (MBChB, M.MED OBGYN) is a pioneer and leading specialist in the care of the mother and child. She also performed the premier in vitro fertilisation (IVF) in Kenya in 2004.
She brings over 30 years of experience as a distinguished medical doctor specialising in maternal and children’s healthcare and policy development in East Africa. She has more than 40 years of experience as a mother and primary caregiver to a neuro-divergent dependent.
“The appointment is fundamentally aligned to iZola’s strategic direction which endeavours to further our mission to transform health journeys for families with special needs,” says iZola CEO, Dr Wamuyu Owotoki. “Her experience as premier mother and child specialist and wealth of knowledge will be instrumental in driving iZola’s aggressive strategic plan.”
> Tougher Options For Loss-Making Nation Media Group
Dr Owotoki added: “It should bring great comfort to families that Dr Leah Kirumbi also comes with the dedication and empathy that can only be forged from being in the trenches faithfully everyday caring for a neuro-divergent child for over four decades.
Dr Owotoki her expertise and dedication to upholding the highest standards of medical care align closely with iZola’s mission and values – and will play a pivotal role in ensuring that it continues to provide customers with excellent solutions that meet their needs.
Dr Leah Kirumbi is a valuable addition to the iZola team, the CEO said. Her expert guidance will be pivotal in ensuring iZola’s solutions adhere to the families they are called to serve.
“I am honoured and privileged to be appointed as the Chief Medical Advisor of iZola,” Dr Kirumbi said. “I am confident that in line with our strategic plan, iZola will continue to further simplify the healthcare journey for children with special needs and their caregivers through continuous product innovation that leverages AI technology.”
